Authors:
LANGREHR JM
GLANEMANN M
GUCKELBERGER O
KLUPP J
NEUMANN U
MACHENS C
LOHMANN R
KNOOP M
LOBECK H
SCHLAG H
KECK H
SETTMACHER U
BECHSTEIN WO
NEUHAUS PJ
Citation: Jm. Langrehr et al., A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY FOR IMMUNOSUPPRESSIVE INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Clinical transplantation, 12(4), 1998, pp. 303-312
Authors:
GLANEMANN M
LANGREHR JM
RAAKOW R
GUCKELBERGER O
LOHMANN R
KLUPP J
LOBECK H
SCHLAG H
KECK H
BECHSTEIN WO
SETTMACHER U
NEUHAUS P
Citation: M. Glanemann et al., ANTI-IL-2 RECEPTOR BT563 VERSUS PLACEBO - A RANDOMIZED TRIAL FOR INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(5), 1998, pp. 2159-2160
Authors:
LANGREHR JM
GLANEMANN M
SCHNELLER A
NEUMANN U
GUCKELBERGER O
LOHMANN R
KLUPP J
JONAS S
KNOOP M
LOBECK H
SCHLAG H
KECK H
SETTMACHER U
BECHSTEIN WO
NEUHAUS PJ
Citation: Jm. Langrehr et al., A RANDOMIZED TRIAL COMPARING ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY ANDPLACEBO FOR IMMUNOSUPPRESSIVE THERAPY AFTER OLT, Transplantation proceedings, 30(4), 1998, pp. 1445-1446
Authors:
LANGREHR JM
NUSSLER NC
NEUMANN U
GUCKELBERGER O
LOHMANN R
RADTKE A
JONAS S
KLUPP J
STEINMULLER T
LOBECK H
MEUER S
SCHLAG H
LEMMENS HP
KNOOP M
KECK H
BECHSTEIN WO
NEUHAUS P
Citation: Jm. Langrehr et al., A PROSPECTIVE RANDOMIZED TRIAL COMPARING INTERLEUKIN-8 RECEPTOR ANTIBODY VERSUS ANTITHYMOCYTE GLOBULIN AS PART OF A QUADRUPLE IMMUNOSUPPRESSIVE INDUCTION THERAPY FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION, Transplantation, 63(12), 1997, pp. 1772-1781
Authors:
LEIMENSTOLL G
ENGEMANN R
GASSEL J
HOFFMANN S
PREUSSE D
SCHLAG H
NIEDERMAYER W
Citation: G. Leimenstoll et al., CYTOKINE SECRETION CAPACITY OF MONONUCLEAR-CELLS IN RENAL-TRANSPLANT RECIPIENTS - THE EFFECT OF 2 DIFFERENT DOSE SCHEDULES, Transplantation proceedings, 25(4), 1993, pp. 2666-2668
Authors:
NEUHAUS P
BECHSTEIN WO
BLUMHARDT G
STEFFEN R
KECK H
LEMMENS P
LANGREHR JM
SCHLAG H
Citation: P. Neuhaus et al., QUADRUPLE INDUCTION IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATION WITH INTERLEUKIN-2 RECEPTOR ANTIBODY (BT 563) IS EQUALLY EFFECTIVE AND BETTER TOLERATED THAN ANTITHYMOCYTE GLOBULIN INDUCTION THERAPY, Transplantation proceedings, 25(2), 1993, pp. 1940-1941
Authors:
NEUHAUS P
BECHSTEIN WO
BLUMHARDT G
WIENS M
LEMMENS P
LANGREHR JM
LOHMANN R
STEFFEN R
SCHLAG H
SLAMA KJ
LOBECK H
Citation: P. Neuhaus et al., COMPARISON OF QUADRUPLE IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATIONWITH ATG OR IL-2 RECEPTOR ANTIBODY, Transplantation, 55(6), 1993, pp. 1320-1327